Yifan Zhao

Yifan Zhao

Auto-generated profile, based on publicly available information

Yifan Zhao

Department of Biomedical Informatics, Harvard Medical School, Boston, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2022 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
LLLovelace J. Luquette
Lovelace J. Luquette
MMMichael B. Miller
Michael B. Miller
ZZZinan Zhou
Zinan Zhou
CBCraig L. Bohrson
Craig L. Bohrson
YZYifan Zhao
Yifan Zhao
PPPeter Park
Peter Park

6 September 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
YZYifan Zhao
Yifan Zhao
HCHuiyu Cai
Huiyu Cai
ZZZuobai Zhang
Zuobai Zhang
JTJian Tang
Jian Tang
YLYue Li
Yue Li
The advent of single-cell RNA sequencing (scRNA-seq) technologies has revolutionized transcriptomic studies. However, large-scale integrative analysis of scRNA-seq data remains a challenge largely due to unwanted batch effects and the limited transferabilty, interpretability, and scalability of the existing computational methods. We present single-cell Embedded Topic Model (scETM). Our key contribution is the utilization of a transferable neural-network-based encoder while having an interpretable linear decoder via a matrix tri-factorization. In particular, scETM simultaneously learns an encoder network to infer cell type mixture and a set of highly interpretable gene embeddings, topic embeddings, and batch-effect linear intercepts from multiple scRNA-seq datasets. scETM is scalable to over 106 cells and confers remarkable cross-tissue and cross-species zero-shot transfer-learning performance. Using gene set enrichment analysis, we find that scETM-learned topics are enriched in biologically meaningful and disease-related pathways. Lastly, scETM enables the incorporation of known gene sets into the gene embeddings, thereby directly learning the associations between pathways and topics via the topic embeddings.

25 April 2025 in Nature Reviews Genetics
Verified
Journal Article
Closed access
PDF file
DSDiane D. Shao
Diane D. Shao
AKAndrea J. Kriz
Andrea J. Kriz
DSDaniel A. Snellings
Daniel A. Snellings
ZZZinan Zhou
Zinan Zhou
YZYifan Zhao
Yifan Zhao
CWChristopher Walsh
Christopher Walsh

1 October 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
YZYifan Zhao
Yifan Zhao
HCHuiyu Cai
Huiyu Cai
ZZZuobai Zhang
Zuobai Zhang
JTJian Tang
Jian Tang
YLYue Li
Yue Li

1 July 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
YZYifan Zhao
Yifan Zhao
LLLovelace J. Luquette
Lovelace J. Luquette
AVAlexander D. Veit
Alexander D. Veit
XWXiaochen Wang
Xiaochen Wang
RXRuibin Xi
Ruibin Xi
PPPeter Park
Peter Park
Improvements in single-cell whole-genome sequencing (scWGS) assays have enabled detailed characterization of somatic copy number alterations (CNAs) at the single-cell level. Yet, current computational methods are mostly designed for detecting chromosome-scale changes in cancer samples with low sequencing coverage. Here, we introduce HiScanner (High-resolution Single-Cell Allelic copy Number callER), which combines read depth, B-allele frequency, and haplotype phasing to identify CNAs with high resolution. In simulated data, HiScanner consistently outperforms state-of-the-art methods across various CNA types and sizes. When applied to high-coverage scWGS data from 65 cells across 11 neurotypical human brains, HiScanner shows a superior ability to detect smaller CNAs, uncovering distinct CNA patterns between neurons and oligodendrocytes. We also generated low-coverage scWGS data from 179 cells sampled from the same meningioma patient at two time points. For this serial dataset, integration of CNAs with point mutations revealed evolutionary trajectories of tumor cells. These findings show that HiScanner enables accurate characterization of frequency, clonality, and distribution of CNAs at the single-cell level in both non-neoplastic and neoplastic cells.

3 November 2025 in bioRxiv
Verified
Preprint
Open access
LLLovelace J. Luquette
Lovelace J. Luquette
TCTim H. H. Coorens
Tim H. H. Coorens
ANAbhiram Natu
Abhiram Natu
MSMilovan Suvakov
Milovan Suvakov
ACAnn Caplin
Ann Caplin
AAAlexij Abyzov
Alexij Abyzov
Single-cell DNA sequencing offers a powerful means of studying somatic mosaicism but requires careful analysis to mitigate DNA amplification-related artifacts. We performed primary template-directed amplification (PTA) and sequencing of 102 nuclei from postmortem lung and colon tissues of a 74-year-old male. Single-cell mutation burdens and spectra were validated by duplex sequencing and revealed heterogeneity across organs and cells, including signatures of APOBEC activity and tobacco exposure. Cells from both tissues exhibited chromosomal aneuploidies, loss of chromosome Y, and chromosomal rearrangements including rearrangements of the T-cell receptor loci indicative of T-cells. Shared embryonic mutations between cells enabled reconstruction of cellular ancestries from the zygote, which were validated by bulk sequencing. Collectively, we demonstrate a comprehensive approach for single-cell genomics that yields an expansive view of diverse somatic mutation types from development through aging across diverse tissues—insights that are obscured in bulk sequencing and only partially captured by other single-cell methods.